Detalles de la búsqueda
1.
Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation.
Haematologica
; 98(5): 765-70, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23300179
2.
Long-term follow-up of an intensified myeloablative conditioning regimen with in vivo T cell depletion followed by allografting in patients with advanced multiple myeloma.
Biol Blood Marrow Transplant
; 16(6): 861-4, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20139025
3.
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.
Haematologica
; 92(8): 1083-90, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17640853
4.
Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM).
Bone Marrow Transplant
; 31(11): 973-9, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12774047
5.
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
J Clin Oncol
; 25(36): 5742-7, 2007 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18089869
6.
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study
Hematologica
; 92(8): 1083-90, 2007. tab, graf
Artículo
en Inglés
| URUCAN | ID: bcc-3812
Resultados
1 -
6
de 6
1
Próxima >
>>